The global allergic rhinitis treatment market is estimated to be valued at US$ 14,916.9 million in 2023 and is expected to exhibit a CAGR of 4.1% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Allergic rhinitis treatment refers to medications used to manage symptoms of allergic rhinitis such as nasal congestion, sneezing, rhinorrhea, and nasal itching. ... Read more
The Allergic Rhinitis Treatment market is estimated to be valued at US$ 18.17 Mn in 2023 and is expected to exhibit a CAGR of 4.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Allergic rhinitis, commonly known as hay fever, is a condition where the inner lining of the nose gets inflamed and swollen by an allergen such as pollen. Some of the common symptoms include ... Read more
Allergic rhinitis, commonly known as hay fever, is an inflammation of the nasal passages caused by an Immunoglobulin E (IgE) immune response to indoor and outdoor allergens such as dust, mold spores, animal dander, and pollen. Symptoms include sneezing, nasal congestion, nasal itching, and runny nose. Antihistamines, corticosteroid nasal sprays, and immunotherapy treatment help provide relief from symptoms.
The global allergic rhinitis treatment market size is ... Read more
Allergic rhinitis is a condition that causes nasal inflammation and congestion in response to allergens such as pollen, dust mites and animal dander. Common symptoms include sneezing, runny nose, nasal congestion and itchy eyes. The global allergic rhinitis treatment market is majorly driven by the rising prevalence of allergic rhinitis around the world. According to studies, over 150 million individuals across the globe suffer from allergic rhinitis. Additionally, factors such as growing ... Read more
